Dr. s.n.-khan (1)

Promoting R&D in the Pharmaceutical Sector Govt of India Initiatives By Dr( Mrs) S.N.Khan,Scientist-F, TDT Divn DST, Ministry of Science & Technology New Delhi-110016 E-mail : Samadk@nic.in

Pharma Sector ,[object Object],[object Object],[object Object]

Need For Strengthening Pharma R&D ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Drug & Pharmaceutical Research ,[object Object],[object Object],[object Object],[object Object],[object Object]

Growth of Indian Drug Industry Year Turnover (Rs .in millions) 1970 3,000 1990 50,000 2005 550,000 2010 1000,000 (Approximate)

Ongoing Initiatives in the Country ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Some Government Initiatives To Promote Indian Pharma Industry ,[object Object],[object Object],[object Object],[object Object],[object Object]

Public Private Partnership R&D Programmes launched by Govt of India ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Drugs & Pharmaceutical Research Programme ,[object Object],[object Object],[object Object]

Demand of DPRP-DST ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Nature of Drug Research ,[object Object],[object Object],[object Object]

Disease Burden in India (Based on WHO-World Health Reports 2002-2004 & Ministry of Health Statistics ) Disease Number of Patients in Millions 1 Cancer 3 2 Hypertension 150 3 Epilepsy 8 4 Depression 10 5 Diabetes 25 6 Schizophrenia 10 7 Asthma 40 8 AIDS 5 9 Alzheimer 1.5 10 Parkinson 2.5 11 Tuberculosis and Malaria 15.0 12 Filariasis 50

International Medical Research Priorities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Steps in New Drug Development ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DST-Led Drugs & Pharmaceuticals Research Programme ,[object Object],[object Object],[object Object],[object Object],[object Object]

DST-LED Technology Development Board (TDB) ,[object Object],[object Object]

DRUGS AND PHARMACEUTICALS RESEARCH PROGRAMME AN OVERVIEW ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Special Features of DPRP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Special Features Of DPRP (Contd) ,[object Object],[object Object],[object Object],[object Object],[object Object]

Drugs and Pharmaceuticals Research Programme (DPRP) Of DST – An Overview . ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DPRP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Terms of Loan(contd) ,[object Object],[object Object]

Drugs & Pharmaceuticals Research Program(DPRP-2004 ONWARDS) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Research activities undertaken in the field of herbal medicines and success achieved in the recent years , challenges faced, efficacies of such drugs along with measures taken to popularise such medicines among people. ,[object Object],[object Object],[object Object]

Vision ,[object Object],[object Object],[object Object]

Vision- Contd… ,[object Object],[object Object]

Diseases Covered ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Institutions involved with Pharmaceuticals Research ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Institutions involved with Pharmaceuticals Research ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MAJOR INDUSTY/INSTITUTIONAL ALLIANCES: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MAJOR INDUSTY/INSTITUTIONAL ALLIANCES: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ALLIANCES( INSTITUTIONS /LABORATORIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Projects Funded for promoting R&D in the Pharma Sector ( Under the D&P Programme ) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Dr. s.n.-khan (1)

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (20)

Similar to Dr. s.n.-khan (1)

Similar to Dr. s.n.-khan (1) (20)

More from Prafulla Tekriwal

More from Prafulla Tekriwal (20)

Recently uploaded

Recently uploaded (20)

Dr. s.n.-khan (1)